JAMA recientes

JAMA recientes 2017-01-13T09:39:10+00:00

Project Description

JAMA - recientes

Highlights for August 14, 2018
14/8/2018
ver resumen

Potential Child Health Consequences of Separating Immigrant Children From Their Parents
14/8/2018
Zucker HA, Greene D.
ver resumen
This Viewpoint discusses how the separation of immigrating children from their parents can result in deleterious long-term physical and psychological effects.

Explaining the Rise in Fatalities From Preventable Injury in Teenagers and Young Adults
14/8/2018
Lee LK, Mannix R.
ver resumen
This Viewpoint reviews CDC injury statistics documenting a rise in preventable fatalities in young people related to opioids, motor vehicle crashes, and firearms, and calls for policies aimed at reversing the trend.

Perinatal Marijuana Use and the Developing Child
14/8/2018
Jansson LM, Jordan CJ, Velez ML.
ver resumen
This Viewpoint assesses the literature regarding marijuana use during pregnancy and whether it is safe to use as an alternative to opioids for pain management among pregnant women.

Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels
14/8/2018
Boumil MM, Curfman G.
ver resumen
This Viewpoint uses recent case law to explore the issue of whether brand-name drug manufacturers can and should be held legally liable for medical harms from generic versions of the same drug produced by other manufacturers with identical labeling.

The Stability of ACA State Health Insurance Marketplaces
14/8/2018
Sacks DW.
ver resumen
This Viewpoint reviews the prospects for collapse faced by ACA-created state health insurance Marketplaces if younger and healthier people disenroll and reviews evidence that the Marketplaces are likely still stable enough to provide coverage despite rising premiums.

A Refugee’s Journey
14/8/2018
Nguyen KM.
ver resumen
In this narrative medicine essay, the author flickers in 55-word scenarios through the life of his father who came to the United States as a Vietnamese refugee through his own life working with refugee children as a youth and now as a physician to reflect that the best of who he is resulted from his father seeking a better life.

Low-Dose Combination Blood Pressure Therapy to Improve Treatment Effectiveness
14/8/2018
Huffman MD, Ogedegbe G, Jaffe M.
ver resumen
In this issue of JAMA, Webster and colleagues report the results of the Triple Pill vs Usual Care Management for Patients with Mild-to-Moderate Hypertension (TRIUMPH) pragmatic randomized clinical trial that evaluated the efficacy of a low-dose combination pill containing 20 mg of telmisartan, 2.5 mg of amlodipine, and 12.5 mg of chlorthalidone compared with usual care among 700 adults with hypertension in Sri Lanka. The primary outcome was the proportion of patients whose blood pressure (BP) was controlled at 6 months, which was defined as a systolic/diastolic BP of less than 140/90 mm Hg or less than 130/80 mm Hg among patients with diabetes or chronic kidney disease at baseline or newly diagnosed (defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2).

Traumatic Brain Injury and Risk of Suicide
14/8/2018
Goldstein L, Diaz-Arrastia R.
ver resumen
Suicide accounts for 1.4% of deaths globally and ranks as the 17th leading cause of death overall and the second for teenagers and young adults. In the United States, suicide is the 10th leading cause of death overall, and the second leading cause of death among teenagers. In 2016, there were nearly 45 000 suicides in the United States, twice the number of homicides, and the US suicide rate has increased in recent years. Suicide occurs throughout the lifespan, in every country, and across all socioeconomic strata. For each suicide, an estimated 20 to 25 suicide attempts occur. Nonfatal suicide behavior, or parasuicide, is frequently accompanied by serious medical and psychiatric comorbidity and long-term disability. Suicide creates enormous psychosocial and economic burdens on individuals, families, caretakers, and society. Yet stigma, shame, and misunderstanding keep suicide in the shadows.

Effect of Cell-Free DNA Screening on Miscarriage in Women With Pregnancies at High Risk of Trisomy 21
14/8/2018
Malan V, Bussières L, Winer N, et al.
ver resumen
This randomized trial compares the effects of maternal Down syndrome screening using plasma cell-free DNA (cfDNA) measures vs invasive screening on miscarriage rates among pregnant women at high risk of trisomy 21 based on first-trimester combined screening.

Effect of Fixed Low-Dose Combination Antihypertensive Medication vs Usual Care on Blood Pressure
14/8/2018
Webster R, Salam A, de Silva H, et al.
ver resumen
This randomized clinical trial compares the effects of a fixed low-dose triple combination antihypertensive pill vs usual care on high blood pressure control among patients with mild or moderate hypertension treated at urban hospital clinics in Sri Lanka.

Association Between Traumatic Brain Injury and Risk of Suicide
14/8/2018
Madsen T, Erlangsen A, Orlovska S, et al.
ver resumen
This cohort study uses Danish national registry data to investigate associations between traumatic brain injury and suicide in the general Danish population between 1980 and 2014.

Effects of Bystander Tourniquet Education and Training on Hemorrhage Control to Help Save Lives
14/8/2018
Fisher AD, Bulger EM, Gestring ML.
ver resumen
This commentary discusses a randomized clinical trial published in JAMA Surgery comparing the effects of point-of-care vs video instructions vs in-person training about tourniquet use on correct tourniquet application and skill retention 3 to 9 months after hemorrhage control training.

Noninvasive Prenatal Genetic Screening Using Cell-free DNA
14/8/2018
Allyse MA, Wick MJ.
ver resumen
This JAMA Clinical Update reviews the use of maternal cell-free DNA (cfDNA) analysis to help screen for fetal aneuploidy trisomies 13, 18, 21, and others).

Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events
14/8/2018
Donadini MP, Bellesini M, Squizzato A.
ver resumen
This Clinical Evidence Synopsis summarizes a Cochrane review of randomized trials comparing the effects of the addition of clopidogrel to aspirin therapy vs aspirin therapy alone among patients at high risk for or with established cardiovascular disease.

BRCA1/2 Testing in Medically Underserved Women With Breast or Ovarian Cancer
14/8/2018
Gross AL, Blot WJ, Visvanathan K.
ver resumen
This study uses US community cohort data to assess BRCA1 and BRCA2 testing among medically underserved Medicare beneficiaries with breast cancer, ovarian cancer, or both.

Trends in Use of Transcatheter Aortic Valve Replacement by Age
14/8/2018
Sedrakyan A, Dhruva SS, Sun T, et al.
ver resumen
This study uses National Inpatient Sample data to characterize trends in transcatheter aortic valve replacement (TAVR) in age groups 55 years and older in the United States from 2012 to 2015.

For Survivors of Intimate Partner Violence, Overlooked Brain Injuries Take a Toll
14/8/2018
Voelker R.
ver resumen
In this Medical News article, experts discuss the importance of screening for intimate partner violence to detect traumatic brain injuries that may lead to serious cognitive deficits.

Administrative Costs and Health Information Technology
14/8/2018
Pearson E, Frakt A.
ver resumen
Identifying effective and sustainable ways to temper the growth of US health care spending has proved to be challenging. One source of high spending in the United States is administrative costs. Taming them is one approach to bending the cost curve, and health information technology (HIT) has often been considered a promising solution.

Fatal Sepsis Linked to Platelets
14/8/2018
Kuehn B.
ver resumen
Clinicians are being urged to monitor patients after platelet transfusion for signs of bacterial infection after 2 separate US outbreaks linked to these blood products led to serious illnesses and deaths.







Feed aggregation powered by Syndicate Press.
Processed request in 1.64668 seconds.

Deje su comentario

Uso de cookies

Este sitio web utiliza cookies para conseguir la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies ACEPTAR

Aviso de cookies

Envía un mensaje

Desde aquí puedes contactar con riesgovascular.org para enviarnos tus comentarios, sugerencias o cualquier otro tema que consideres oportuno

Intentaremos contestar lo antes posible.